Lidia Fonseca
Chief Digital and Technology Officer, Executive Vice President
Lidia Fonseca is the Executive Vice President, Chief Digital and Technology Officer at Pfizer, responsible for the enterprise-wide digital strategy. Lidia leads all digital, data and technology products and solutions across the company, including digitizing drug discovery, clinical development, manufacturing, distribution and commercial. Her team accelerates innovation at Pfizer by enhancing operational processes through automation and robotics, and delivering powerful insights with data, advanced analytics, and artificial intelligence (AI) for better and faster decision-making. She is also responsible for Pfizer Learning and Development and Business Process Excellence. As the intersection of Digital and healthcare expands, Lidia is spearheading the effort to improve patient health outcomes through innovative digital health, medicines, and diagnostics products.
Our People
Nico Gariboldi
Vice President, Thessaloniki Site Lead
Dimitris Papakonstantinou
Finance Lead
Sofia Sidira
Operations lead | DEI Lead
Vivi Ntrigkogia
Sr. Manager, Communications
Ioulia Despoinoudi
Sr. Manager, Learning and Development
Anastasia Matonaki
Technology and Innovation Senior Manager
Thanos Stavropoulos
Technology and Innovation Senior Manager
Gianna Sventzidou
Sr. Manager, Digital Best Practice Studio
Ioanna Georgiou
Manager, TA Greece
Eleni Theologou
Sr People Experience Manager, Center for Digital Innovation
How we work
Our Working Principles
We develop transformative digital solutions to drive breakthroughs that change patients’ lives. As a team of interconnected people, we work with excellence, courage, equity and joy to implement the best ideas as fast as possible.
We use agile co-creation process
We collaborate with colleagues, partners, patients, healthcare providers and others around the world to accelerate breakthroughs and deliver scalable solutions as fast as possible.
We deliver results-driven, multidisciplinary performance
We pursue state of-the-art processes that lead to measurable outcomes across various fields, from therapeutics, to design thinking analysis and Artificial Intelligence.
We take a patient-centric approach to develop digital solutions
We strive every day to enhance our patients’ lives through disruptive innovation.
We are part of a global network
We are a diverse group of people, with global connections, engaging with the external local ecosystem to facilitate co-development partnerships.
Innovation in CDI
With Pfizer’s purpose and values in mind, CDI works with agility, efficiency, and focus in collaboration with key stakeholders and partners. We firmly believe in exchanging ideas that will help us excel and reach our goals always with the patient in mind. To do that, we cultivate a relationship with the external innovation ecosystem that will help us excel on our mission. By applying open innovation principles we connect global organization opportunities to a local ecosystem of partners to research, co-pilot/prototype and test innovative digital solutions. With open innovation, we are set on a path to develop transformative digital solutions to drive breakthroughs that change patients’ lives in collaboration with ecosystem stakeholders namely startups, research centers, universities, healthcare professionals and patient associations.
